Abstract:Previous work in this laboratory has demonstrated that cerebral hypoperfusion increases the expression of prostaglandin endoperoxide synthase‐2 (PGHS‐2) in ovine fetal brain regions. Endogenously produced prostaglandins, in turn, partially mediate the fetal hypothalamus‐ pituitary‐adrenal (HPA) axis response to arterial hypotension. In separate experiments, we have found that oestradiol stimulates fetal HPA axis activity. The present experiments were designed to test the hypothesis that oestradiol increases the expression of PGHS isoforms, and that oestradiol augments the PGHS response to cerebral hypoperfusion. Sixteen fetal sheep of known gestational ages (124–128 days' gestation at the time of study) were subjected to chronic catheterization and implantation of extravascular occluder around the brachiocephalic artery. Eight fetuses were subjected to subcutaneous implantation of a pellet containing 17β‐oestradiol (release rate 5 mg (21 days)−1). Brachiocephalic occlusion (BCO) stimulated adrenocorticotropin (ACTH), cortisol and arginine vasopressin (AVP) secretion, responses that were augmented by oestradiol. One hour after the beginning of a 10 min period of BCO, PGHS‐1 mRNA was increased in fetal brainstem and hypothalamus, and PGHS‐2 mRNA was increased in fetal brainstem. Oestradiol, by itself, increased the abundance of PGHS‐2 mRNA in brainstem and cerebellum, and augmented the PGHS‐2 mRNA response to BCO in brainstem. In contrast, oestradiol had no significant effect on the abundance of PGHS‐1 mRNA in any brain region. PGHS‐1 and PGHS‐2 protein levels did not reflect the changes in the respective mRNAs. The abundance of both proteins was increased in cerebral cortex in response to BCO, and the abundance of PGHS‐2 protein was increased by both oestradiol and BCO in the hippocampus. The results of this study confirm and extend the results of our previous studies, demonstrating an effect of cerebral hypoperfusion on the expression of both isoforms of PGHS. We conclude that oestradiol increases the expression of PGHS‐2 in specific fetal brain regions, and that there is an interaction between oestradiol and BCO in the control of PGHS‐2 expression in the fetal brainstem. We expect that at later time‐points, the changes in mRNA would be followed by similar changes in enzyme abundance at the protein level. We speculate that at least a part of the effect of oestradiol on fetal HPA axis function is mediated by an interaction between oestradiol and prostaglandin biosynthesis in the fetal brain.

Efficient Photocatalytic Degradation of Antibiotics by Visible Light-Driven Red Phosphorus/znal-Ldh Heterostructures: Mineralization Activity and Actual Farming Wastewater Treatment

Facile design and fabrication of RP/ZnIn 2 S 4 composite photocatalysts with efficient removal of antibiotics under visible-light irradiation

Central Nervous System Prostaglandin Endoperoxide Synthase‐1 and −2 Responses to Oestradiol and Cerebral Hypoperfusion in Late‐Gestation Fetal Sheep

Population‐Based Assessments of Clinical Drug‐Drug Interactions: Qualitative Indices or Quantitative Measures?

Piezoresistance for polycrystalline aggregates represented by crystallite orientation distribution function

Synergistic Effect for Enhanced Photodegradation of Antibiotic Pollutant

Intelligent multifunctional ruthenium monoatomic/ZnAl-LDH photocatalysts for simultaneous detection and rapid degradation of antibiotics

Efficient degradation of tetracycline in wastewater by novel biochar-based photocatalytic materials: performance, photocatalytic mechanism and degradation pathways

Recent Advances in Photocatalytic Degradation of Tetracycline Antibiotics

Rate of ubiquinone oxidation in electron transport particles reduced by succinate.

Peroxymonosulfate-assisted photocatalysis system enhanced magnetic Fe3O4@P-C3N4 treatment of tetracycline wastewater: Multi-pathways mediated electrons migration to generate reactive species

Visible Light-Induced Periodate Activation by Bi2wo6@Nitrogen-Deficient C3n4 Composites for Efficient Degradation of Tetracycline Hydrochloride

Visible-light-driven tetracycline hydrochloride degradation via ZnTi-LDHs/Ce 2 S 3 Z-scheme heterojunctions: Performance and mechanistic analysis

Efficiency and Mechanistic Insights of Photocatalytic Degradation and Sterilization Utilizing G-C3n4/wo3-x Z-scheme Heterojunction under Full-Spectrum Light

The epidemic of AIDS: a failure of public health policy.

Fabrication of water-floating litchi-like polystyrene-sphere-supported TiO2/Bi2O3 S-scheme heterojunction for efficient photocatalytic degradation of tetracycline

Facile construction of a fascinating Z-scheme AgI/Zn3V2O8 photocatalyst for the photocatalytic degradation of tetracycline under visible light irradiation

Carbon quantum dots-modified tetra (4-carboxyphenyl) porphyrin/BiOBr S-scheme heterojunction for efficient photocatalytic antibiotic degradation

Photocatalytic synergistic biofilms enhance tetracycline degradation and conversion

Study on highly efficient p-n heterojunction Bi2MoO6/Cu2O: Synthesis, characterization and visible-light photocatalytic activity toward antibiotics degradation

Photocatalysis: Light‐Activated Rapid Disinfection by Accelerated Charge Transfer in Red Phosphorus/ZnO Heterointerface (small Methods 3/2019)